phase readout
saveNCT05500807: Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
RECRUITINGupdated just now
community read0 votes
Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois. Phase: PHASE1. Conditions: Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
view source ↗
comments(0)
5-min edit window · permanent after that